CSRXP ANALYSIS FINDS BIG PHARMA’S DIRECT-TO-CONSUMER (DTC) ADVERTISING COSTS U.S. TAXPAYERS BILLIONS OF DOLLARS
Study Finds Reducing or Taxing Brand Name Drug Companies’ Nearly $14 Billion… Read More
Study Finds Reducing or Taxing Brand Name Drug Companies’ Nearly $14 Billion… Read More
Cracking Down on Anti-Competitive Tactics Like Patent-Thicketing and… Read More
U.S. Senate Confirmation Hearing Called Attention to Big Pharma’s Egregious… Read More
Across Political Spectrum, Fabrizio Ward Finds Voters Identify Pharmaceutical… Read More
Voters Across the Political Spectrum Identify Pharmaceutical Company Profits… Read More
Big Pharma’s Innovation Rhetoric Designed to Keep Drug Prices High Rather… Read More
Brand Name Manufacturers’ Prices for Blockbuster GLP-1 Medications Are… Read More
Campaign Looks Forward to Working with Kennedy and the Administration to Lower… Read More
Brand Name Drug Company Known for Egregious Product-Hopping Strategy Beats… Read More
Eli Lilly Signals Plan to Maintain Unsustainably High Prices on Blockbuster… Read More
Pharmaceutical Giants Continue to Outperform Wall Street Projections While… Read More
Major Pharmaceutical Companies Continue Growing Revenues While Sticking With… Read More